Sentinel lymph node molecular pathology in breast carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Surgical Pathology

Background:

• Accurate staging of breast cancer relies on primary tumor resection and axillary lymph node evaluation.
• Traditional histopathological methods like Hematoxylin-Eosin (HE) staining may miss micrometastases in sentinel lymph nodes (SLN).
• Immunohistochemistry (IHC) offers improved sensitivity but may still not detect all metastatic cells.

Purpose of the Study:

• To investigate the utility of molecular biology techniques, specifically reverse-transcription polymerase chain reaction (RT-PCR), for detecting mammaglobin A and B messenger RNA in breast cancer SLNs.
• To compare the sensitivity of RT-PCR with conventional methods (HE and IHC) for identifying lymph node metastases.

Main Methods:

• Prospective study of 50 breast cancer patients' sentinel lymph nodes (SLNs) between June 2004 and August 2006.
• Intraoperative cytology, HE staining, and IHC with cytokeratin (AE1-AE3) were performed on 2 mm sections.
• Multiplex RT-PCR was employed to detect mammaglobin A and B mRNA in SLN samples.

Main Results:

• Routine techniques identified subcapsular metastasis in 3/50 cases; IHC detected 5/50 cases (2 negative by HE).
• Multiplex RT-PCR detected mammaglobin mRNA in 18/50 SLNs, including the 5 cases identified by IHC.
• RT-PCR identified 13 additional positive SLNs not detected by HE or IHC, indicating superior sensitivity for micrometastasis detection.

Conclusions:

• Standard HE staining is insufficient for detecting all SLN micrometastases, impacting patient staging and treatment.
• The multiplex RT-PCR technique for mammaglobin A and B mRNA is a specific and sensitive method for SLN analysis.
• Wider adoption of IHC and molecular techniques like RT-PCR for SLN examination is recommended to improve breast cancer patient management.